Paper10629546
Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
Hindermann W and 6 others. J Pathol, 1999. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. Papers, record 10629546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10629546
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Mouth Neoplasms | Major topic |
| Neoplasm Proteins | Major topic |
| Tenascin | Major topic |
| Basement Membrane | |
| Humans | |
| Immunohistochemistry | |
| In Situ Hybridization | |
| Mouth Mucosa | |
| Protein Isoforms | |
| RNA, Neoplasm | |
| Statistics, Nonparametric |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41044643 | LCP1 upregulation via EGFR signaling promotes oral cancer progression through the JAK2/STAT3/IL-1β axis. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41044643 | PubMed |
| 36230826 | Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230826 | PubMed |
| 35785162 | Revisiting the Tenascins: Exploitable as Cancer Targets? | Front Oncol | 2022 | https://conductscience.org/library/papers/35785162 | PubMed |
| 31140150 | Phage display screening of therapeutic peptide for cancer targeting and therapy. | Protein Cell | 2019 | https://conductscience.org/library/papers/31140150 | PubMed |
| 28106752 | The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28106752 | PubMed |
| 28095396 | Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28095396 | PubMed |
| 26731558 | Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. | PLoS One | 2016 | https://conductscience.org/library/papers/26731558 | PubMed |
| 25908786 | Identification of recurrent regulated alternative splicing events across human solid tumors. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25908786 | PubMed |
| 25793577 | Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25793577 | PubMed |
| 25793576 | Tenascin-C and integrins in cancer. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25793576 | PubMed |
| 25738825 | Tenascin C in metastasis: A view from the invasive front. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25738825 | PubMed |
| 25695402 | Role of tenascins in the ECM of gliomas. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25695402 | PubMed |
| 25562532 | The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25562532 | PubMed |
| 25482829 | Tenascin-C: Form versus function. | Cell Adh Migr | 2015 | https://conductscience.org/library/papers/25482829 | PubMed |
| 24481545 | Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats. | Transl Stroke Res | 2014 | https://conductscience.org/library/papers/24481545 | PubMed |
| 24250086 | Molecular changes in invasive front of oral cancer. | J Oral Maxillofac Pathol | 2013 | https://conductscience.org/library/papers/24250086 | PubMed |
| 22075565 | Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery. | Histochem Cell Biol | 2012 | https://conductscience.org/library/papers/22075565 | PubMed |
| 20678196 | Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. | Breast Cancer Res | 2010 | https://conductscience.org/library/papers/20678196 | PubMed |
| 20237793 | A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies. | Histochem Cell Biol | 2010 | https://conductscience.org/library/papers/20237793 | PubMed |
| 19326143 | B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? | J Cancer Res Clin Oncol | 2009 | https://conductscience.org/library/papers/19326143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10629546
GET https://conductscience.org/api/papers/v1/10629546/cited_by?page=2